These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2390689)

  • 1. Comparison of 5-fluorouracil pharmacokinetics following intraperitoneal and intravenous administration using in vivo 19F magnetic resonance spectroscopy.
    Glaholm J; Leach MO; Collins D; al Jehazi B; Sharp JC; Smith TA; Adach J; Hind A; McCready VR; White H
    Br J Radiol; 1990 Jul; 63(751):547-53. PubMed ID: 2390689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superiority of hepatic arterial infusion in preventing catabolism of 5-FU compared with portal vein infusion revealed by an in vivo 19F NMR study.
    Okuno K; Hirai N; Lee YS; Tarabar D; Ueno H; Yasutomi M
    Cancer Chemother Pharmacol; 1998; 42(4):341-4. PubMed ID: 9744781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of 5-fluorouracil catabolism in human liver in vivo by three-dimensional localized 19F magnetic resonance spectroscopy.
    Li CW; Negendank WG; Padavic-Shaller KA; O'Dwyer PJ; Murphy-Boesch J; Brown TR
    Clin Cancer Res; 1996 Feb; 2(2):339-45. PubMed ID: 9816177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In-vivo 19F-MRS study of 5-fluorouracil (5-FU) metabolism on tumors].
    Harada M; Nishitani H; Shirahama T; Koga K; Miura I
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):75-80. PubMed ID: 1899014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug monitoring of 5-fluorouracil: in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma.
    Schlemmer HP; Bachert P; Semmler W; Hohenberger P; Schlag P; Lorenz WJ; van Kaick G
    Magn Reson Imaging; 1994; 12(3):497-511. PubMed ID: 8007780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic comparison of intraperitoneal and intravenous 5-Fu administration].
    Qing SH
    Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):340-2. PubMed ID: 1782844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 19F-[1H] nuclear Overhauser effect and proton decoupling of 5-fluorouracil and alpha-fluoro-beta-alanine.
    Krems B; Bachert P; Zabel HJ; Lorenz WJ
    J Magn Reson B; 1995 Aug; 108(2):155-64. PubMed ID: 7648013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the biodistribution and catabolism of 5-fluorouracil in tumor-bearing rats by chemical-shift selective 19F MR imaging.
    Brix G; Bellemann ME; Haberkorn U; Gerlach L; Bachert P; Lorenz WJ
    Magn Reson Med; 1995 Sep; 34(3):302-7. PubMed ID: 7500866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of 5-fluorouracil and its catabolites determined by 19F nuclear magnetic resonance spectroscopy for a patient on chronic hemodialysis.
    Rengelshausen J; Hull WE; Schwenger V; Göggelmann C; Walter-Sack I; Bommer J
    Am J Kidney Dis; 2002 Feb; 39(2):E10. PubMed ID: 11840401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effect of 5-ethynyluracil on 5-fluorouracil metabolism determined by 19F nuclear magnetic resonance spectroscopy.
    Adams ER; Leffert JJ; Craig DJ; Spector T; Pizzorno G
    Cancer Res; 1999 Jan; 59(1):122-7. PubMed ID: 9892196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head and neck carcinoma during simultaneous radiochemotherapy.
    Schlemmer HP; Becker M; Bachert P; Dietz A; Rudat V; Vanselow B; Wollensack P; Zuna I; Knopp MV; Weidauer H; Wannenmacher M; van Kaick G
    Cancer Res; 1999 May; 59(10):2363-9. PubMed ID: 10344745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct detection of intratumoral 5-fluorouracil trapping using metabolic 19F MR imaging.
    Brix G; Bellemann ME; Gerlach L; Haberkorn U
    Magn Reson Imaging; 1999 Jan; 17(1):151-5. PubMed ID: 9888408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by 18F PET and 19F MRI: a comparative animal study.
    Brix G; Bellemann ME; Haberkorn U; Gerlach L; Lorenz WJ
    Nucl Med Biol; 1996 Oct; 23(7):897-906. PubMed ID: 8971857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective 19F MR imaging of 5-fluorouracil and alpha-fluoro-beta-alanine.
    Brix G; Bellemann ME; Zabel HJ; Bachert P; Lorenz WJ
    Magn Reson Imaging; 1993; 11(8):1193-201. PubMed ID: 8271906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic fibrosis does not affect the pharmacokinetics of 5-fluorouracil in rats.
    Nagata M; Hidaka Y; Hatakeyama K; Kawano Y; Iwakiri T; Okumura M; Arimori K
    Biopharm Drug Dispos; 2011 Mar; 32(2):126-30. PubMed ID: 21341281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic analysis of sparse in vivo NMR spectroscopy data using relative parameters and the population approach.
    Port RE; Schlemmer HP; Bachert P
    Eur J Clin Pharmacol; 1994; 47(2):187-93. PubMed ID: 7859808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time follow-up of 5-fluorouracil metabolism in the liver of tumor patients by means of F-19 MR spectroscopy.
    Semmler W; Bachert-Baumann P; Gückel F; Ermark F; Schlag P; Lorenz WJ; van Kaick G
    Radiology; 1990 Jan; 174(1):141-5. PubMed ID: 2104675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of fluorouracil and folinic acid.
    Schalhorn A; Kühl M
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):82-92. PubMed ID: 1557660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies on the metabolism of new fluorinated pyrimidine drugs in the liver by in vivo 19F magnetic resonance spectroscopic observation.
    Harada M; Nishitani H; Koga K; Miura I; Kimura A
    Jpn J Cancer Res; 1993 Feb; 84(2):197-202. PubMed ID: 8463136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.
    Hull WE; Port RE; Herrmann R; Britsch B; Kunz W
    Cancer Res; 1988 Mar; 48(6):1680-8. PubMed ID: 3125967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.